Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- dyspnea on exertion
- decreased exercise tolerance
- lower extremity edema
- holosystolic murmur
Otros factores de diagnóstico
- fatigue
- displaced point of maximal impulse
- orthopnea
- paroxysmal nocturnal dyspnea
- palpitations
- diaphoresis
- pulmonary closure is louder than aortic closure
- S3 heart sound
- diminished S1 heart sound
Factores de riesgo
- mitral valve prolapse
- history of rheumatic heart disease
- infective endocarditis
- history of cardiac trauma
- history of myocardial infarction
- history of congenital heart disease
- history of ischemic heart disease
- left ventricular systolic dysfunction
- hypertrophic cardiomyopathy
- anorectic/dopaminergic drugs
- elevated systolic blood pressure
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- transthoracic echo
- ECG
Pruebas diagnósticas que deben considerarse
- flow convergence method or proximal isovelocity surface area
- color Doppler flow
- transesophageal echocardiogram
- cardiac catheterization
- cardiac magnetic resonance imaging (CMR)
Algoritmo de tratamiento
acute severe MR
chronic severe primary MR: asymptomatic
chronic severe primary MR: symptomatic
chronic severe secondary MR
Colaboradores
Autores
Prakash P. Punjabi, FRCS, FESC, MS, MCh, FCCP, FFSTEd, Diplomate NBE
Professor
National Heart and Lung Institute
Imperial College London
Consultant Cardiothoracic Surgeon
Department of Cardiothoracic Surgery
Hammersmith Hospital
Imperial College Healthcare NHS Trust
London
UK
Divulgaciones
PPP is an author of references cited in this topic. PPP declares that he has no competing interests.
Agradecimientos
Dr Prakash P. Punjabi would like to gratefully acknowledge Dr Samir Kapadia and Dr Mehdi H. Shishehbor, previous contributors to this topic.
Divulgaciones
SK and MHS declare that they have no competing interests.
Revisores por pares
Matthew Czarny, MD
Assistant Professor of Medicine
Department of Cardiovascular Medicine
Johns Hopkins University School of Medicine
Baltimore
MD
Divulgaciones
MC is a paid consultant to Medtronic and receives research grants to the institution as a site principal investigator for clinical trials for Medtronic, MedAlliance, and Abbott and a sub-investigator for clinical trials for Edwards Lifesciences. All of these companies manufacture devices used in the transcatheter treatment of structural heart and/or coronary artery disease.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
De Bonis M, Al-Attar N, Antunes M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J. 2016 Jan 7;37(2):133-9.Texto completo Resumen
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo Resumen
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.Texto completo Resumen
Bonow RO, O'Gara PT, Adams DH, et al. 2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 May 5;75(17):2236-70.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Acute coronary syndrome (ACS)
- Infective endocarditis
- Mitral stenosis
Más DiferencialesGuidelines
- 2023 ESC guidelines for the management of infective endocarditis
- 2021 ESC/EACTS guidelines for the management of valvular heart disease
Más GuidelinesVideos
Mitral regurgitation (severe)
Third heart sound gallop
More videosLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer